Cannabis Consumption and Driving Impairment Assessment on a Closed Course

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-03

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In a true experiment, roughly 300 volunteer participants will smoke active cannabis, a corresponding placebo, or no substance at all (control). Next, participants will complete a drive test and then be observed by actual California Highway Patrol (CHP) officers who will attempt to classify participants as impaired or unimpaired. CHP Officers will evaluate participants in the context of driving (i.e., while following participants in an actual patrol car), as part of a roadside behavioral assessment (i.e., the Advanced Roadside Impaired Driving Enforcement, or ARIDE, battery, which includes Standardized Field Sobriety Tests, or SFSTs), and as part of a Drug Recognition Expert (DRE) evaluation conducted indoors.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Inhaled Cannabis on Driving Performance

NCT01620177

Alcohol Drinking Cannabis

COMPLETED NA

The Impact and Detection of Driving Impairments Associated With Acute Cannabis Smoking

NCT02849587

Cannabis Intoxication

COMPLETED PHASE1/PHASE2

Marijuana Effects on Simulated Driving Performance

NCT03699540

Cannabis Cannabis Use Marijuana +2 more

COMPLETED PHASE1

Effects of THC and Alcohol on Driving Performance

NCT03555968

Cannabis Alcohol Drinking Accident, Traffic

WITHDRAWN PHASE4

Effect of Cannabis on Simulated and Actual Driving in Healthy Subjects

NCT01118364

Healthy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The easing of restrictions on the use of cannabis for recreational purposes presents a new challenge for policing of impaired driving, which is to say Driving Under the Influence of Drugs (DUI-D), specifically cannabis. In particular, it is not entirely clear how well the tools used by law enforcement officers to detect driving impairment (e.g., behavioral instruments such as the SFSTs, as included in the ARIDE battery) work for identifying cannabis-induced driving impairment specifically. While these instruments are designed to help officers identify driving impairment in general (irrespective of cause), prior empirical validation work has almost exclusively involved alcohol-induced impairment. This study will be conducted within a realistic, closed-course driving environment and it seeks to validate the same instruments currently used by law enforcement to detect cannabis-induced driving impairment against a second, independent, behavioral standard for driving impairment: a comprehensive driver evaluation adapted from the same set of driver tests that Californians must pass upon application for an original license, or (in certain instances) when referred to the Department of Motor Vehicles (DMV) for evaluation of their ability to safely operate a non-commercial class of motor vehicle (here referred to as the Modified Driver Performance Evaluation or MDPE).

This study seeks to answer the following research questions:

I. How accurately do behavioral assessments used by officers distinguish between drivers impaired by cannabis and drivers not impaired by cannabis?

II. How does cannabis affect real-world (as opposed to simulated) driving performance?

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cannabis Smoking Driving Impaired

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This study is a true experiment in a naturalistic setting designed to maximize ecological validity, that is, designed so that the findings can be expected to generalize to their real-world application of detecting impaired driving. The study features a randomized between-subjects design, in which the main independent variable (Substance) has three levels: active cannabis vs. placebo vs. control (i.e., no substance).

Primary Study Purpose

OTHER

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Participants are blind to condition assignment, meaning they are not told in advance which version of the procedure they will experience. While those assigned to the true control condition will obviously realize this during the session, remaining participants are not informed whether the cigarette they smoke contains active cannabis or placebo.

Similarly, the experimenters will necessarily become aware of which individuals are in the control conditions, however, they do not know which of the remaining participants are assigned to active cannabis versus placebo conditions (i.e., the active vs. placebo cannabis cigarettes are not labeled as such).

Most importantly, outcome assessors such as the officers and driving evaluators who supply the ratings that comprise the focal dependent variables will be completely blind to experimental condition, so that there is no straightforward means by which experimenter bias could affect data collected for those variables.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active Smoked Cannabis

Participants in this arm will smoke an active cannabis cigarette containing 18.16% Δ9-tetrahydrocannabinol (THC). The smoking will occur at each participant's preferred pace, but will be limited to a maximum ten-minute period. While individual doses vary in this type of paradigm (ad libitum dosing), the anticipated dose of THC within the cannabis condition can be approximated by the following formula: (700 mg of cannabis) x \[% of cigarette smoked; maximum of 70% (allowing room to hold the cigarette)\] x (% THC). Therefore, the maximum dose in this arm is 700 mg x 70% x 18.2% = 89.18 mg of THC. Individual participants will only take part in the study under a single condition and receive the active cannabis once.

Bulk cannabis for this arm will be provided by the National Institute on Drug Abuse Drug Supply Program; cannabis cigarettes will be prepared and prescribed by the Research Pharmacy of the University of California, San Diego.

Group Type EXPERIMENTAL

Active smoked cannabis

Intervention Type DRUG

Assessment of active cannabis smoking and driving impairment

Placebo Smoked Cannabis

Participants in this arm will smoke a placebo cannabis cigarette containing \<.01 THC. The smoking will occur at each participant's preferred pace, but will be limited to a maximum ten-minute period. Individual participants will only take part in the study under a single condition and receive the placebo cannabis once.

Bulk placebo for this arm will be provided by the National Institute on Drug Abuse Drug Supply Program; placebo cannabis cigarettes will be prepared and prescribed by the Research Pharmacy of the University of California, San Diego.

Group Type PLACEBO_COMPARATOR

Placebo smoked cannabis

Intervention Type DRUG

Assessment of placebo cannabis smoking and driving impairment

Control

Participants in this arm receive no cannabis. Individual participants will only take part in the study under a single condition.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Active smoked cannabis

Assessment of active cannabis smoking and driving impairment

Intervention Type DRUG

Placebo smoked cannabis

Assessment of placebo cannabis smoking and driving impairment

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

marijuana, cannabis sativa, C. sativa L., C. sativa. Cannabis sativa L., Cannabis indica, C. indica marijuana placebo, cannabis placebo, placebo marijuana, placebo cannabis

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Possessing a valid California driver's license
* Cannabis use in the past six months
* Willing and able to abstain from alcohol, cannabis, and other recreational drugs for 24 hours prior to scheduled participation
* Willing and able to avoid driving and operating heavy machinery for at least four hours after participation
* Residence within approximately 15 miles of the study site
* Possessing the capacity to provide informed consent

Exclusion Criteria

* Completion of a roadside sobriety test during the previous 12 months
* Physical or psychological conditions that can be exacerbated by cannabis use, or for which cannabis use is contraindicated
* Potential presence of Cannabis Use Disorder as assessed by a modified version of the Cannabis Use Disorder Identification Test
* Potential presence of Substance Use Disorder as assessed by a modified version of the Drug Abuse Screening Test
* Pregnancy or breastfeeding reported
* Unwillingness to be transported by taxi
* Having been convicted of Driving Under the Influence (DUI) within five years prior to scheduled participation
* Parole or probation status
* One or more felony convictions on record involving aggressive or dangerous criminal activity
* Any of the following at the time of the experimental session: breath alcohol content of .01% or greater; positive pregnancy test; cannabis consumption considered unsafe following medical checkup by the study nurse; or driving test behavior considered hazardous by the driving examiner

Minimum Eligible Age

21 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes